Transcat (NASDAQ:TRNS) Issues Earnings Results

Transcat (NASDAQ:TRNS) announced its quarterly earnings data on Monday. The scientific and technical instruments company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.20, Zacks reports. The firm had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $69.35 million. Transcat had a return on equity of 9.23% and a net margin of 5.69%. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.38 EPS.

Transcat Price Performance

TRNS stock traded up $1.17 during trading on Wednesday, reaching $118.08. 32,571 shares of the company were exchanged, compared to its average volume of 42,579. The company has a market capitalization of $1.08 billion, a price-to-earnings ratio of 74.03 and a beta of 0.68. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.14 and a quick ratio of 2.62. The company has a 50-day moving average of $127.73 and a two-hundred day moving average of $115.77. Transcat has a twelve month low of $82.60 and a twelve month high of $147.12.

Wall Street Analyst Weigh In

A number of research firms recently commented on TRNS. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price target on shares of Transcat in a research note on Tuesday. Oppenheimer upped their price target on shares of Transcat from $125.00 to $160.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. Northland Capmk lowered shares of Transcat from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 22nd. Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 22nd. Finally, Craig Hallum reduced their target price on Transcat from $150.00 to $138.00 and set a “buy” rating on the stock in a report on Wednesday. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $151.33.

Insider Activity at Transcat

In other Transcat news, CEO Lee D. Rudow sold 12,000 shares of the business’s stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $135.10, for a total transaction of $1,621,200.00. Following the sale, the chief executive officer now owns 91,692 shares of the company’s stock, valued at $12,387,589.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Transcat news, CEO Lee D. Rudow sold 3,343 shares of the company’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $124.12, for a total value of $414,933.16. Following the completion of the transaction, the chief executive officer now owns 103,692 shares of the company’s stock, valued at approximately $12,870,251.04. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Lee D. Rudow sold 12,000 shares of Transcat stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $135.10, for a total value of $1,621,200.00. Following the sale, the chief executive officer now directly owns 91,692 shares in the company, valued at $12,387,589.20. The disclosure for this sale can be found here. Insiders sold a total of 22,215 shares of company stock valued at $2,969,084 in the last quarter. Insiders own 4.20% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.